Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Svetomir N Markovic
Academic and Community Cancer Research United
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Saint Mary'S Medical Center
San Francisco, California, United States
- Mayo Clinic in Florida
Jacksonville, Florida, United States
- University of Illinois
Chicago, Illinois, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Siouxland Regional Cancer Center
Sioux City, Iowa, United States
- Cancer Research Consortium of West Michigan Ncorp
Grand Rapids, Michigan, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, United States
- Missouri Valley Cancer Consortium
Omaha, Nebraska, United States
- Roswell Park Cancer Institute
Buffalo, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Saint Vincent Hospital Cancer Center Green Bay
Green Bay, Wisconsin, United States
- University of Wisconsin Hospital and Clinics
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Oct 2013
- Primary completion
- 24 May 2017
- Completion
- 30 Oct 2019
- Last update posted
- 21 Jan 2020
- Registered enrollment
- 24
- Registry id
- NCT02158520
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.